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Background: Over the past few years, there has been a worldwide significant increase in
the incidence of type II diabetes mellitus with both increase in morbidity and mortality.
Controlling diabetes through life style modifications, including diet and exercise has
always been the cornerstone in diabetes management. Increasing evidence suggests
that the Mediterranean diet could be of benefit in diseases associated with chronic
inflammation, including metabolic syndrome, diabetes, obesity as well as atherosclerosis,
cancer, pulmonary diseases, and cognition disorders As a matter of fact, a number of
studies addressed the relationship between Mediterranean diet and diabetes control. The
result of these studies was conflicting. Some were able to elicit a protective role, while
others showed no added benefit. As a result; we decided to conduct a systematic review
to have a better understanding of the relationship between adherence to Mediterranean
diet and diabetes control.
Methods: A systematic review was conducted on the effect of Mediterranean diet in
diabetes control and cardiovascular risk modification as well as the possible mechanism
through which this diet might exhibit its beneficial role. We did a comprehensive search
of multiple electronic databases such as Medline, Google Scholars, PubMed, and the
Cochrane central register data until May 2014. We included cross-sectional, prospective,
and controlled clinical trials that looked at the associations between Mediterranean diet
and indices of diabetes control such HbA1c, fasting glucose, and homeostasis model
assessment, in addition to cardiovascular and peripheral vascular outcomes.
Outcome/conclusion: Most of the studies showed favorable effects of Mediterranean
diet on glycemic control and CVD, although a certain degree of controversy remains
regarding some issues, such as obesity. Important methodological differences and
limitations in the studies make it difficult to compare results, thus further longer term
studies are needed to evaluate the long-term efficacy of the Mediterranean diet along
with the possibility of explaining its mechanism.
Keywords: Mediterranean diet, dietary pattern, type II diabetes, glycemic control, HbA1c, insulin resistance,
cardiovascular risk
Introduction
According to the World Health Organization (WHO) reports, chronic illnesses contribute to 60%
of death worldwide (1). Being a major chronic disease; type II diabetes (T2DM) seems to be one
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of the leading causes of mortality and of public health burden (2).
The increasing incidence of diabetes worldwide has been highly
linked to the westernized dietary patterns, physical inactivity, and
increasing rates of obesity and metabolic syndrome.
Over the past few years, there has been a great effort to study the
relationship between dietary patterns and human health. Inter-
estingly, adherence to a healthy life style was strongly associated
with reduction in the risk of chronic illnesses (83% reduction in
coronary artery disease and 91% reduction in diabetes mellitus
in females) (3). Moreover, PREDIMED – Reus study nutrition
intervention trial showed that adherence to Mediterranean diet
was associated with 52% reduction of diabetes mellitus inci-
dence (4).
The American Diabetes Association (ADA) does not recom-
mend a specific diet over another for the diabetic patients. How-
ever, it clearly states that the total amount of fat should rep-
resent 25–35%, and saturated fat of <7% of the total calories,
with monounsaturated fat as the major source of fat intake. It
also points out the importance of adequate amounts of fruits,
vegetables, and whole wheat cereals.
On the other hand, the ADA lists three different types of diets
(either low-carbohydrate, or low-fat calorie-restricted orMediter-
ranean diet) as a mean for weight loss for individuals who have or
are at risk of having diabetes (5). Because of the abovementioned
heterogeneous data and controversial evidence regarding the best
dietary pattern in diabetic patients, there was a need to conduct
a systematic review to highlight the effect of adherence to a
Mediterranean diet on diabetes control and cardiovascular risks.
The term Mediterranean diet was first coined by Ancel Keys
in the 1960s. Keys observed the dietary habits adopted by the
population residing near the Mediterranean Sea and noticed a
reduced incidence of chronic illnesses and higher life expectancy
when compared to other regions of the world (6). Defining the
term Mediterranean diet is a great challenge given the broad
geographical distribution of the Mediterranean countries and the
ethnic, cultural, religious, and economic variations among them.
However despite this, there is a dietary pattern characteristic of the
Mediterranean diet. This includes a diet rich in fruits, vegetables,
bread, cereals, olive oil as the major source of fat, low to moderate
amounts of fish and poultry and alcohol, and little red meat.
Assessing adherence to Mediterranean diet is not a simple task.
For this reason, many indexes were developed to describe the
degree of adherence to the Mediterranean diet. Trichopoulo et al.
designed a score for assessing the diet adherence (7). In his scoring
system, Trichopoulo granted individuals points depending on
their daily intake of the separate components of theMediterranean
diet. A score of 9 reflected the highest degree of adherence.
Panagiotakos et al. developed another score, which assesses the
monthly intake of Mediterranean food rather than the daily one,
with a score range of 0–55 (8).
Methods
In this study, we conduct a systematic review to assess the rela-
tionship between the Mediterranean diet and diabetes control.
We have searched PubMed, Medline, Google scholars. and the
Cochrane central register databases using exploded mesh terms
“Mediterranean,” “diet,” “dietary pattern,” “type two diabetes,”
“glycemic control,” “HBA1c,” “insulin resistance,” “insulin sensi-
tivity,” “homeostasis model assessment (HOMA),” “Cardiovascu-
lar disease,” ”Coronary artery disease “ and “peripheral arterial
disease,” “mechanism of action,” and “antioxidant”(Appendix).
During our search, there were no language restrictions. We also
used references from the articles and reviews we extracted to
complete the data bank. We identified cross-sectional, prospec-
tive, and controlled clinical trials that looked at the associa-
tions between Mediterranean diet and indices of diabetes con-
trol such as HbA1c, fasting glucose, and HOMA, in addition to
cardiovascular and peripheral vascular outcomes. Studies with
participants number <15 or follow up period <3months were
excluded. We also excluded studies that assessed adherence
to Mediterranean diet subjectively without the use of a score,
those with case control design, and those that analyzed adher-
ence to a non-specific dietary pattern rather than a Mediter-
ranean diet.
Our initial search yielded 72 articles, of which 25 were excluded
on the basis of abstract.
Exclusion of the abstracts was based on the content and its
relevance to our review, and whether it fits our inclusion/exclusion
criteria. Most of the abstracts reviewed had full text available. Of
the remaining 47 articles, 23 articles were excluded for either not
having diabetic patients in the study population, or for being a
case-control design, or having evaluated a non-specific dietary
pattern rather than Mediterranean diet, or having short follow up
period (<3months), or a limited number of participants (<15).
A total of 24 studies were included by the end of the search
(Figure 1).
25 excluded based 
on abstracts
47 poten!ally relevant 
ar!cles screened for 
retrieval 
23 excluded:
-no diabe!c pa!ents in 
the study popula!on
-case control design
-nonspeciﬁc dietary 
pa#ern
-short follow up period 
(<3 months)
-limited number of 
par!cipants ( <15)
24 Ar!cles included in 
Review
72 Records iden!ﬁed 
through database 
search
FIGURE 1 | Flow diagram of the systematic literature search.
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Mediterranean Diet and Diabetes Control
Six randomized control studies, and one randomized cross-over
study have assessed the effect ofMediterranean diet on parameters
of glycemic control including glucose levels, HbA1c, and insulin
resistance (Table 1). Out of these seven randomized trials, four
were specifically designed to evaluate the effect of Mediterranean
diet on glycemic control in T2DM patients (9–12). While in
the other three studies, T2DM patients were a subgroup of the
design sample (13–15). Most of these studies demonstrated the
effectiveness and superiority of Mediterranean diet in glycemic
control and insulin sensitivity in T2DM patients when compared
to control diets (low-fat diet/usual dietary habits).
Mediterranean Diet Effect on Plasma Glucose
and HbA1c
There has been good evidence that adherence to Mediterranean
diet might have a beneficial role in glycemic control.
In fact, Esposito et al. conducted a cross-sectional analysis of
a population of 901 diabetic outpatients attending diabetes clinic
in south Italy. In this study, adherence to Mediterranean diet
was inversely associated with both postprandial glucose levels
and HbA1c. In multivariate analysis, mean HbA1c and 2-h post-
meal glucose concentrations were significantly lower in diabetic
patients with high adherence to aMediterranean-type diet (adher-
ence score 6–9) compared to thosewith low adherence [difference:
HbA1c 0.9%, 95% confidence intervals (CI) 0.5–1.2%, P< 0.001;
2-h glucose 2.2mmol/l, 95% CI 0.8–2.9mmol/l, P< 0.001] (16).
Another recent cross-sectional study evaluated 383 participants
with type 2 diabetes participating in the PREDIMED trial and
looked at the relation between HbA1c levels and adherence to
Mediterranean diet. After adjusting for age and sex, there was
a trend toward an inverse association between adherence to
Mediterranean diet and HbA1c levels, which did not reach statis-
tical significance. Multivariate analysis additionally adjusted for
physical activity, smoking, time of evaluation of T2DM, body
mass index (BMI), and insulin treatment found similar findings
(OR= 0.69, 95% CI 0.17–2.83) (17).
One study looked at the HbA1c in 279 postmenopausal dia-
betic women who were randomized to receive either usual care
TABLE 1 | List of randomized studies on effect of Mediterranean diet on fasting glucose and HbA1c.
Study author Study population Intervention Follow-up period End point results
Toobert et al.
(9)
279 diabetic
postmenopausal
women
Control diet (low fat) vs. MLP* 6-month randomized
controlled clinical trial
HbA1c: decreased in Mediterranean arm ( 0.4% from
baseline in MLP group); P value <0.01
No change in control group
Estruch et al.
(13)
772 High risk
individuals (421
diabetics)
Mediterranean diet (either virgin
oil or mixed nuts rich) vs. low-fat
diet
3-month randomized
controlled clinical trial
Fasting glucose level: decreased in Mediterranean arm (mean
difference  7mg/dl in olive oil Mediterranean diet group
compared to low-fat diet group); P value <0.017
Shai et al.
(14)
322 Moderately
obese patients (36
diabetics)
Low-fat restricted calorie diet vs.
Mediterranean calorie-restricted
diet vs. low carbohydrate
non-restricted calorie diet
2-year randomized
controlled clinical trial
 Diabetic patients:
Fasting glucose:
Decreased in Mediterranean arm (by  32.8mg/dl in the
Mediterranean diet compared to baseline and increased by
12.1mg/dl in low-fat diet; P value 0.001;
HbA1c:
No change between groups
 Non-diabetic patients
Fasting glucose:
No change between the three groups;
HbA1c:
No change between groups
Esposito
et al. (16)
215 patients with
newly diagnosed
diabetes
Mediterranean diet vs. low-fat
diet
4-year randomized
controlled clinical trial
Fasting glucose: decreased in Mediterranean arm ( 21mg/dl
difference in the Mediterranean diet arm compared to low-fat
diet); P value <0.01; HbA1c: decreased in Mediterranean
arm ( 0.6% difference between arms)
Elhayany
et al. (11)
259 overweight
diabetic patients.
Low carbohydrate Mediterranean
diet vs. traditional Mediterranean
diet vs. ADA diet
12-month randomized
controlled clinical trial
Fasting glucose: no significant change; HbA1c: decreased
(difference  0.4% change between low carbohydrate
Mediterranean diet and ADA); P value 0.002
Itsiopoulous
et al. (12)
27 diabetic patients Mediterranean diet vs. usual diet
over 12weeks then cross over to
alternate diet
12weeks Randomized
cross-over
interventional study
HbA1c: decreased ( 0.3% Change between different
groups); P value 0.012
Lasa et al.
(15)
191 diabetic
patients
A low-fat diet (LFD) vs a MD
supplemented with 1 L/week of
extra-virgin olive oil or a MD
supplemented with 30 g/day of
mixed tree nuts
12-month randomized
controlled clinical trial
HOMA-IR levels: no significant change (all P>0.05)
Adiponectin/leptin Ratio: increased in all three trial arms (all
P<0.05)
Adiponectin/HOMA-IR ratio: increased in the MD
supplemented with olive oil group (P= 0.027) and showed a
trend toward increase in the MD supplemented with nuts
(P=0.069) and the LFD (P= 0.061) groups
*Mediterranean Lifestyle Program: comprehensive life style self-management program (including Mediterranean low saturated fat diet, stress management training, exercise and smoking
cessation).
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(control) or comprehensive life style self-management program
that included a Mediterranean diet. There was a significant
decrease in theHbA1c in theMediterranean diet arm (7.43–7.07%
P= 0.001) as compared to the control (7.4%) after 6months (9).
Estruch et al. also evaluated the effects of two types of Mediter-
ranean diets (either supplemented with 1 l/week of virgin olive oil
or 30 g/day of tree nuts) and a low-fat diet on fasting glucose in 772
high risk patients of which 54.5% are diabetics. After 3months,
both types of Mediterranean diets had significantly lower level
of fasting glucose compared to the low-fat diet (13). In another
comparative study between threeweight loss diets (Mediterranean
diet, low-fat diet, and low carbohydrate diet) in 322 moderately
obese patients of which 36 are diabetics, Shai et al. found a
significant decrease in the fasting plasma glucose level in the
diabetic patients receiving the Mediterranean diet ( 32.8mg/dl)
compared to low-fat diet. There was no change in the fasting
plasma levels in non-diabetic patients receiving any form of the
threeweight loss diets. Furthermore; therewas no difference in the
drop in the HbA1c level among patients receiving Mediterranean
diet or low-fat diet ( 0.5% 1.1% vs. 0.4 1.3% P= 0.45) (14).
The metabolic effects of a Mediterranean diet compared to a low-
fat diet were further evaluated by Esposito et al. on 215 patients
with newly diagnosed diabetes. After 1 year, both the fasting glu-
cose level and the HbA1c were lower in the Mediterranean diet
arm (10).
Another study conducted by Elhayany et al. also evaluated the
change in HbA1c and fasting glucose in 259 diabetic patients
on stable anti hyperglycemic medication on either low carbo-
hydrates Mediterranean diet, or traditional Mediterranean diet,
or the American association diabetes diet (ADA diet). Elhayany
et al. found a non-significant decrease in fasting glucose and a
significant reduction in HbA1c in patients allocated to the low
carbohydrates Mediterranean diet (11).
A recent randomized controlled study studied twenty-seven
subjects with type 2 diabetes who were randomly assigned to
consume either the Mediterranean intervention diet (ad libitum)
or their usual diet for 12weeks, and then cross over to the alternate
diet and looked at their HbA1c control. Compared with the usual
diet, patients on the ad libitum Mediterranean intervention diet
had significant drop of their glycosylated hemoglobin from 7.1 to
6.8% (P= 0.021) with a significant improvement in the quality of
diet (12).
Mediterranean Diet Effect on Insulin Resistance
The association between Mediterranean diet and insulin sensi-
tivity was studied in a Greek adult population. In this study, an
inverse association between Mediterranean diet and indices of
glucose homeostasis and insulin resistance (assessed by HOMA)
was found. However, it is worth noting, that this association was
only evident in non-diabetic patients subgroup (18). Another
clinical trial evaluated the HOMA-IR in patients with diabetes
at 24months after being randomized either to Mediterranean
diet or low-fat diet. In his study, Shai et al. found a greater
drop in HOMA index in patients with diabetes adherent to
the Mediterranean diet compared to low-fat diet (14). Esposito
et al. found a similar inverse relation between Mediterranean
diet and HOMA-IR in 215 newly diagnosed type two diabetics
after 1 year of either receiving a Mediterranean diet or low-fat
diet (10).
In contrast to these findings, there was no difference in
HOMA index at 1 year in 116 diabetic patients assigned to either
Mediterranean diet or ADA diet on stable antiglycemic med-
ications (11). Lasa et al. had similar results in a recent mul-
ticenter parallel trial. This trial was conducted on 191 partic-
ipants (77 men and 114 women) of the PREDIMED study in
order to compare the effects of three different dietary interven-
tions (two Mediterranean diets supplemented with olive oil or
mixed nuts and a low-fat diet, LFD) on body weight and glucose
metabolism. After 1 year of follow up, increased values of both
adiponectin/leptin ratio (P= 0.043, P= 0.001, P< 00.01 for low
fat, olive oil, and nut diets respectively) and adiponectin/HOMA-
IR ratio (P= 0.061, P= 0.027, P= 0.069 for low fat, olive oil,
and nut diets respectively)and significant decreased values of
waist circumference were observed in all three diet arms. In both
Mediterranean diet groups, but not in the low-fat group these
findings were associated with significant reduction in bodyweight
(P= 0.347, P= 0.03 and P= 0.021 for low fat, olive oil and nut
diets) (15).
Diabetes Complication and Risk Factors
In addition to the possible protective effect of Mediterranean
diet on glycemic control and homeostasis, growing data suggests
potential role for this type of diet in improving cardiovascular
risk factors, decreasing mortality, and reducing peripheral artery
disease in diabetic patients (10, 11, 13, 19–22).
Cardiovascular Risk Factors
The effects of Mediterranean diet on cardiovascular risk factors
in diabetic patients was evaluated by Esposito et al. and Elhayany
et al. in the above mentioned two controlled studies (10, 11).
Both authors were able to show an improvement in systolic blood
pressure, HDL level, ratio of total cholesterol to HDL, and triglyc-
erides level in diabetic patients adherent toMediterranean diet, as
well as a significant weight reduction when compared to control
diet. Estruch et al. also had similar results concerning cardiovas-
cular risk parameters (systolic blood pressure, cholesterol/HDL
ratio) after 3months of randomizing 772 asymptomatic patients,
of which 50% were diabetics, to either low-fat diet (n= 257) or
Mediterranean diet (rich in virgin olive oil or tree nuts (13).
However, this study did not conduct any sub-analysis for the
diabetic patients.
Interestingly, Frazer et al. found lowest levels of aminotrans-
ferase in the Mediterranean arm in a post hoc analysis of a
quasi-randomized controlled trial in T2DM patients allocated to
Mediterranean diet, ADA diet, or low glycemic diet. This find-
ing made the authors speculate on the potential beneficial effect
of the Mediterranean diet on liver steatosis (23). Moreover, the
results of 12-week prospective study in 14 obese men with non-
alcoholic fatty liver and metabolic syndrome profile showed a
great improvement in the steatosis degree (complete regression
in 21.4%, and overall improvement in 92.86% of the patients),
emphasizing more about the possible beneficial role of Mediter-
ranean diet. It is worth noting that none of the patients included
in this study was diabetic (24).
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Cardiovascular Disease and Total Mortality
There are no clinical trials that look solely at the mortality and
cardiovascular risk reduction in diabetic patients on Mediter-
ranean diet. However, a number of randomized trials evaluated
the effect of the aforementioned diet on the cardiovascular and
mortality risk attenuation in the high risk population which
included diabetic patients. As a matter of fact, Hodge et al. cal-
culated a personal Mediterranean diet score (MDS) for total of
40,000 participant (of which 2150 had either frank diabetes or
high glucose levels) recruited from the Melbourne collaborative
cohort study between 1990 and 1994. He collected total and
cardiovascular mortality data up to 2003. In his analysis, Hodge
found an expected increased risk of both total and cardiovascu-
lar mortality in diabetic patients (HR 1.4% for men, 1.86%for
women). In this study, the hazard ratios (HR) for total mor-
tality per unit of MDS were 0.96 and 0.94%, the HRs for the
cardiovascular mortality per unit of MDS were 0.94 and 0.94%
in men and women respectively. These data suggest a small
reduction inmortality with increased adherence toMediterranean
diet (19).
Singh et al. tested an “Indo Mediterranean diet” in 1000 high
risk individuals including 190 diabetic patients. He found a one
third reduction in incidence of fatal myocardial infarction and
about two third reduction of sudden death from cardiovascular
reasons in the Indo Mediterranean diet arm when compared to
the controlled diet (20). However, this particular study is not
considered to be in support of the beneficial role of Mediter-
ranean diet onmortality and cardiovascular risk especially that an
expression of concern has been issued against it (25). The GISSI
Prevenzione clinical trial in Italy encouraged 11,323 individuals
(1700 diabetics) with history of myocardial infarction to increase
their daily consumption ofMediterranean diet components. After
comparing the adherence scores, people with highest scores had
an odds ratio ofmortality of 0.51%when compared to participants
with lowest scores emphasizing again on the positive role that
Mediterranean diet can exhibit (21).
Peripheral Artery Disease
There is not enough data on the effect of Mediterranean diet on
peripheral artery disease. However, the association between the
risk of peripheral artery disease and adherence to Mediterranean
diet was addressed in one cross-sectional study of 944 Italian
patients with diabetes. A higher MDS was independently related
to a reduction of peripheral artery disease risk, with an odds ratio
of 0.44% (95% CI 0.24–0.83) (22).
Mechanism of Protective Role of
Mediterranean Diet in Diabetes
A number of studies were conducted to explore the possible
mechanisms of action of a Mediterranean diet in controlling
diabetes as well as reducing its cardiovascular risk factors and
mortality. There are no adequate studies assessing the mechanism
of action of Mediterranean diet in diabetic patients, but some
trends can be extrapolated from studies conducted in patientswith
metabolic syndrome. It seems that each dietary component of the
Mediterranean diet have a vital role in the possible protective role.
An anti-inflammatory role has been long thought to be one
of the mechanisms through which olive oil rich Mediterranean
diet acts. The effects of two different Mediterranean diets on
immune cell activation and inflammatory markers in 112 indi-
viduals with diabetes (60%) or high cardiovascular risk patients
compared to low-fat diet was studied by Mena et al. in a short
term interventional trial. After 3months, expression of adhesion
molecules on monocytes and IL6 circulating levels significantly
decreased after adherence to both types of Mediterranean diets
but not after low-fat diet (26). On the other hand, such an anti-
inflammatory effect couldn’t be elicited in a 1-year randomized
trial in 101 patients with coronary artery disease including 9%
of diabetic patients (27). Another randomized trial conducted on
high risk patients including diabetics found a significant drop
in CRP levels in patients adherent to Mediterranean diet rich
in olive oil as compared to low-fat diet (13). Many studies sug-
gest a role for oleic acid, the predominant monosaturated fatty
acid in olive oil, in lowering insulin resistance through increas-
ing adiponectin (28–30), however there are contradictory results
concerning this particular effect on insulin resistance (31, 32).
The antioxidant characteristic of its rich content of fruits, veg-
etables and cereals seems to play a major role in its protec-
tive potential. Interestingly, Evan et al. demonstrated how pro-
longed oxidative stress was associated with increased beta cell
dysfunction as well as insulin resistance (33). Furthermore, two
clinical trials showed that administration of antioxidant vita-
mins improved insulin sensitivity (34, 35). Sanchez-Moreno et al.
reported a reduced amount of F2 isoprostane, a marker of oxida-
tive stress and increased vitamin C levels in healthy individuals
on a typical Mediterranean plate (36). Recently, Barona et al.
was able to show that Mediterranean-style low-glycemic-load
diet for 12weeks in thirty five women with metabolic syndrome
and high LDL levels (>100mg/dl) significantly reduced oxidized
LDL (12% in Mediterranean diet) (37). Moderate alcohol con-
sumption, as part of the dietary pattern in the Mediterranean
diet seemed to have a beneficial effect on insulin resistance by
increasing adiponectin levels (38) as it was observed on multiple
epidemiological studies (39–41). This was supported by a cross-
sectional study conducted on 987 diabetic women, a subsample
of the Nurse Health Study that demonstrated that patients with
highest adherence to Mediterranean diet had 23% higher levels
of adiponectin compared to those with lowest Mediterranean diet
adherence (42).
Another important component of the Mediterranean diet is
dietary fiber which is believed to induce satiety and thus reduce
caloric intake (43–45).
Conclusion
In this systemic review, the potential positive role and health ben-
efits of Mediterranean diet on diabetes control and its cardiovas-
cular complications were explored. Despite the difficulty to assess
adherence to such a diet, the limited number of studies focusing on
the full effects ofMediterranean diet in diabetic subjects, the strict
exclusion/inclusion criteria followed, there is good evidence that
adherence toMediterranean diet seems to have a protective role on
glycemic control as reflected by reduced HbA1c and lower fasting
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levels in addition to decreased insulin resistance and mortality.
Decreasing oxidative stress, inflammation, and insulin resistance
are all possible mechanism by which Mediterranean diet pauses
as a protective dietary pattern. Concerning cardiovascular risk
modification, there is some cardiovascular benefit of adhering to
a Mediterranean diet in diabetic patients; although there are no
studies looking at the cardiovascular outcome in diabetic patients
only. This fact necessitates further studies to assess the effect of
adherence toMediterranean diet on cardiovascular risk in diabetic
patients.
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